Vericel Corp. buy melinda
Start price
07.10.17
/
50%
€4.42
Target price
03.01.18
€5.41
Performance (%)
20.41%
End price
03.01.18
€5.32
Summary
This prediction ended on 03.01.18 with a price of €5.32. The prediction had a final performance of 20.41%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vericel Corp. | 1.935% | 1.935% | -42.018% | 42.471% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to melinda what are the pros and cons of Vericel Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Vericel Corp. diskutieren
Arzneimittel
Als solche wiederholten Zimmerman eine Kaufempfehlung für Aktien von Vericel, mit einem Zielpreis von $ 6,00, eine mögliche Zunahme von 13% gegenüber , wo die Lager zu sein Verhandlung 
Stopped prediction by melinda for Vericel Corp.
Vericel Corp.
Start price
Target price
Perf. (%)
€30.20
19.08.23
19.08.23
-
19.08.24
19.08.24
40.40%
20.08.24
20.08.24
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€10.85
11.03.20
11.03.20
€15.00
04.11.21
04.11.21
288.94%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€2.85
23.04.16
23.04.16
€4.96
24.10.16
24.10.16
-22.47%
24.10.16
24.10.16
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€11.74
01.04.13
01.04.13
€14.00
01.10.13
01.10.13
-70.70%
01.10.13
01.10.13
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€49.92
11.01.11
11.01.11
€80.00
11.07.11
11.07.11
-24.88%
11.07.11
11.07.11
Could be worthwhile Investment >10% per year